You just read:

BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronie's Disease

News provided by

BioSpecifics Technologies Corp.

Oct 12, 2010, 02:30 ET